Inhibition of [3H]TdR and [3H]CdR incorporation in an established human lymphoma cell line by trypsin treatment.
D000818:Animals; D002460:Cell Line; D002469:Cell Separation / Q000379:methods; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003841:Deoxycytidine / Q000378:metabolism*; D006367:HeLa Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000378:metabolism*; D008545:Melanoma / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000378:metabolism; D012513:Sarcoma, Experimental / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism*; D014357:Trypsin / Q000494:pharmacology*
D004273:DNA, Neoplasm; D003841:Deoxycytidine; D014357:Trypsin; D013936:Thymidine